Pharma Journalist -

Seattle Genetics announced that it has submitted a supplemental Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) based on data from the phase 3…
Read More...

Lonza and TRACON Pharmaceuticals announced the successful delivery of the first 2,000L single-use bioreactor (SUB) batch produced from the recently expanded Lonza Singapore site. The…
Read More...

MilliporeSigma launched its new BioContinuum Platform to advance biotherapeutic drug manufacturing through improved efficiency, simplified plant operations and greater quality and…
Read More...

Eli Lilly and Company and NextCure announced a multi-year collaboration focused on the discovery and development of immuno-oncology therapies. The collaboration seeks to discover novel…
Read More...

Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has approved LORBRENA® (lorlatinib), a third-generation anaplastic lymphoma kinase (ALK) tyrosine kinase…
Read More...

NuMedii announced the formation of a research collaboration with Johns Hopkins School of Medicine with the goal of discovering new targets and therapeutic options for pancreatitis. The…
Read More...

Understanding your audience through digital channels is key in today's healthcare world, as patients are using devices and moving more onto online communications to contact and find…
Read More...

Denali Therapeutics Inc. announced that it will collaborate with Sanofi on the development of multiple RIPK1 inhibitor molecules with the potential to treat a range of neurological and…
Read More...

Pharmaceutical Product Development, LLC (PPD) has enhanced its global product development services, adding significant expertise in multiple therapeutic areas, including neuroscience,…
Read More...

PMI BioPharma Solutions, a specialty CDMO providing Contract Research, Drug Discovery, Development and Manufacturing Services officially formed in January of 2018, announced that David…
Read More...